M3, Inc. Announces Consolidated and Non-Consolidated Earnings Results for the Fiscal Year Ended March 31, 2021
April 23, 2021 at 02:00 am EDT
Share
M3, Inc. announced consolidated and non-consolidated earnings results for the fiscal year ended March 31, 2021. For the year on consolidated basis, the company reported net sales of ¥169,198 million against ¥130,973 million a year ago. Operating profit was ¥57,972 million against ¥34,337 million a year ago. Net profit was ¥41,198 million against ¥24,153 million a year ago. Basic earnings per share was ¥55.73 against ¥31.89 a year ago. Diluted earnings per share was ¥55.68 against ¥31.88 a year ago.
For the year on non-consolidated basis, the company reported net sales of ¥49,911 million against ¥27,012 million a year ago. Operating profit was ¥28,031 million against ¥13,548 million a year ago. Net profit was ¥21,994 million against ¥12,232 million a year ago.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
M3, INC. 
